Cargando…
Chloroquine: Can it be a Novel Drug for COVID-19
Coronavirus disease 2019 (COVID-19) has been declared a pandemic by the World Health Organization. The United States Food and Drug Administration has not approved any drug or vaccine for the treatment of COVID-19; however, reports have emerged from different parts of the world about the potential th...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7189906/ https://www.ncbi.nlm.nih.gov/pubmed/32363157 http://dx.doi.org/10.4103/ijabmr.IJABMR_141_20 |
_version_ | 1783527589710659584 |
---|---|
author | Badyal, Dinesh Kumar Mahajan, Rajiv |
author_facet | Badyal, Dinesh Kumar Mahajan, Rajiv |
author_sort | Badyal, Dinesh Kumar |
collection | PubMed |
description | Coronavirus disease 2019 (COVID-19) has been declared a pandemic by the World Health Organization. The United States Food and Drug Administration has not approved any drug or vaccine for the treatment of COVID-19; however, reports have emerged from different parts of the world about the potential therapeutic benefits of existing drugs. Chloroquine and phosphate hydroxychloroquine are the drugs currently in the limelight, and recently, the National Task Force for COVID-19 constituted by the Indian Council of Medical Research has recommended the use of antimalarial drug hydroxychloroquine for prophylaxis of severe acute respiratory syndrome-coronavirus 2 infection in selected high-risk individuals. This short write-up explores the potential efficacy and established safety of chloroquine in COVID-19. |
format | Online Article Text |
id | pubmed-7189906 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-71899062020-04-30 Chloroquine: Can it be a Novel Drug for COVID-19 Badyal, Dinesh Kumar Mahajan, Rajiv Int J Appl Basic Med Res New Perspective Coronavirus disease 2019 (COVID-19) has been declared a pandemic by the World Health Organization. The United States Food and Drug Administration has not approved any drug or vaccine for the treatment of COVID-19; however, reports have emerged from different parts of the world about the potential therapeutic benefits of existing drugs. Chloroquine and phosphate hydroxychloroquine are the drugs currently in the limelight, and recently, the National Task Force for COVID-19 constituted by the Indian Council of Medical Research has recommended the use of antimalarial drug hydroxychloroquine for prophylaxis of severe acute respiratory syndrome-coronavirus 2 infection in selected high-risk individuals. This short write-up explores the potential efficacy and established safety of chloroquine in COVID-19. Wolters Kluwer - Medknow 2020 2020-04-02 /pmc/articles/PMC7189906/ /pubmed/32363157 http://dx.doi.org/10.4103/ijabmr.IJABMR_141_20 Text en Copyright: © 2020 International Journal of Applied and Basic Medical Research http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | New Perspective Badyal, Dinesh Kumar Mahajan, Rajiv Chloroquine: Can it be a Novel Drug for COVID-19 |
title | Chloroquine: Can it be a Novel Drug for COVID-19 |
title_full | Chloroquine: Can it be a Novel Drug for COVID-19 |
title_fullStr | Chloroquine: Can it be a Novel Drug for COVID-19 |
title_full_unstemmed | Chloroquine: Can it be a Novel Drug for COVID-19 |
title_short | Chloroquine: Can it be a Novel Drug for COVID-19 |
title_sort | chloroquine: can it be a novel drug for covid-19 |
topic | New Perspective |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7189906/ https://www.ncbi.nlm.nih.gov/pubmed/32363157 http://dx.doi.org/10.4103/ijabmr.IJABMR_141_20 |
work_keys_str_mv | AT badyaldineshkumar chloroquinecanitbeanoveldrugforcovid19 AT mahajanrajiv chloroquinecanitbeanoveldrugforcovid19 |